Applied BioCode Corporation (6598.TW) TAI

Currency In TWD

AD

Applied BioCode Corporation

Address

Grand Pavilion, Hibiscus Way, 802 West Bay Road, P.O. Box 31119

Grand Cayman, CA KY1-1205

Cayman Islands (the)

Phone

833 246 2633

Sector

Healthcare

Industry

Medical - Devices

Employees

43

First IPO Date

February 09, 2017

Key Executives

NameTitlePayYear Born
Winston Z.Founder, Chief Executive Officer, President & Director42,000N/A
Jaca Liang-Kai HuangChief Financial Officer & Corporate Governance Officer6.17MN/A
Yu-Tsung ChouChief Information Officer0N/A
Zhao Gu ChenAccounting Director0N/A
Jim LeighSenior Vice President of Sales0N/A
Ingrid JosephAdministration Division Director0N/A
Ruei-E TangAdministration Division Director0N/A
Parisa HanachiVice President of Marketing0N/A
Beth LadermanChief Scientific Officer0N/A
AD

Description

Applied BioCode Corporation specializes in the complete lifecycle—from design and development to manufacturing and commercialization—of multiplex diagnostic testing solutions tailored for the In-Vitro Diagnostics (IVD) market. Among its key offerings are two sophisticated systems: the BioCode MDx 3000, an automated molecular diagnostics platform that streamlines PCR amplification, hybridization, and detection steps; and the BioCode 2500 analyzer, specifically engineered to read barcoded magnetic beads (BMBs) and display their unique identification along with fluorescence intensity. The company also boasts an extensive portfolio of diagnostic assays, including the BioCode SARS-CoV-2 Assay, a high-throughput, automated nucleic acid multiplex test for detecting SARS-CoV-2 genetic material in nasopharyngeal swabs. Other panels comprise BioCode Respiratory Pathogen Panels, capable of simultaneously identifying and differentiating seventeen distinct respiratory pathogens in nasopharyngeal samples, and BioCode gastrointestinal (GI) pathogen panels, which target prevalent GI pathogens such as viruses, bacteria, and parasites responsible for infectious diarrheal diseases. An expanding pipeline of MDx assays for various molecular tests is also under development. Beyond these, Applied BioCode provides specialized reagents like analyte-specific reagents for fungal pathogens, and multiplex kits for human cytokines and chemokines, vital for biomarker identification. For research flexibility, they offer premixed and customizable multiplex kits for mouse models, alongside similar cytokine/chemokine multiplex kits for rat, monkey, canine, and non-human primate studies. Rounding out its comprehensive services, the company supplies its proprietary BMBs, calibration beads, and coupling kits for a wide array of bioassay applications. They also offer ELISA (Enzyme-Linked Immunosorbent Assay), a method for the precise quantification of drug, protein, or antibody levels in biological samples such as cell lysates or serum, in addition to providing full-spectrum assay development services. Applied BioCode Corporation is headquartered in Santa Fe Springs, California.

AD